Indomethacin for prevention of heterotopic ossification after hip arthroplasty: A randomized comparison between 4 and 8 days of treatment

Ulrich Dorn; Claude Grethen; Harald Effenberger; Hans Berka; Thomas Ramsauer; Thomas Drekonja

doi:10.3109/17453679809117607

Indomethacin for prevention of heterotopic ossification after hip arthroplasty: A randomized comparison between 4 and 8 days of treatment

Authors

Ulrich Dorn
Claude Grethen
Harald Effenberger
Hans Berka
Thomas Ramsauer
Thomas Drekonja

DOI:

https://doi.org/10.3109/17453679809117607

Abstract

In a randomized, parallel group study, we evaluated the efficacy of a 4-day versus an 8-day course of indomethacin (50 mg, 3 times per day), given as prophylaxis against heterotopic ossification after formation. cementless total hip arthroplasty in 209 patients with arthrosis. Patients receiving the prophylaxis for 8 days had less (p = 0.03) severe heterotopic bone

Downloads

Download data is not yet available.

Downloads

Published

1998-01-01

How to Cite

Dorn, U., Grethen, C., Effenberger, H., Berka, H., Ramsauer, T., & Drekonja, T. (1998). Indomethacin for prevention of heterotopic ossification after hip arthroplasty: A randomized comparison between 4 and 8 days of treatment. Acta Orthopaedica, 69(2), 107–110. https://doi.org/10.3109/17453679809117607

Download Citation

Issue

Acta Orthopaedica, Volume 69, Issue 2 (1998)

Section

Articles

License

Acta Orthopaedica (Scandinavica) content is available freely online as from volume 1, 1930. The journal owner owns the copyright for all material published until volume 80, 2009. As of June 2009, the journal has however been published fully Open Access, meaning the authors retain copyright to their work. As of June 2009, articles have been published under CC-BY-NC or CC-BY licenses, unless otherwise specified.